These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19070490)

  • 1. Survival in SMA type 1.
    Kaufmann P; Greiss C; Brown J
    Neuromuscul Disord; 2009 Jan; 19(1):76; author reply 76. PubMed ID: 19070490
    [No Abstract]   [Full Text] [Related]  

  • 2. Survival probabilities of patients with childhood spinal muscle atrophy.
    Mannaa MM; Kalra M; Wong B; Cohen AP; Amin RS
    J Clin Neuromuscul Dis; 2009 Mar; 10(3):85-9. PubMed ID: 19258855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Global management of infantile spinal muscular atrophy. Practical guide for medical staff].
    Delmas MC; Bérard C
    Pediatrie; 1990; 45(7-8):457-64. PubMed ID: 2170920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of goal-directed non-invasive ventilation and mechanical insufflation/exsufflation in spinal muscular atrophy type I.
    Chatwin M; Bush A; Simonds AK
    Arch Dis Child; 2011 May; 96(5):426-32. PubMed ID: 20573738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Special considerations in the respiratory management of spinal muscular atrophy.
    Schroth MK
    Pediatrics; 2009 May; 123 Suppl 4():S245-9. PubMed ID: 19420154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spinal muscular atrophy type 1: management and outcomes.
    Bach JR; Baird JS; Plosky D; Navado J; Weaver B
    Pediatr Pulmonol; 2002 Jul; 34(1):16-22. PubMed ID: 12112792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The changing natural history of spinal muscular atrophy type 1.
    Oskoui M; Levy G; Garland CJ; Gray JM; O'Hagen J; De Vivo DC; Kaufmann P
    Neurology; 2007 Nov; 69(20):1931-6. PubMed ID: 17998484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. POINT: Is Noninvasive Ventilation Always the Most Appropriate Manner of Long-term Ventilation for Infants With Spinal Muscular Atrophy Type 1? Yes, Almost Always.
    Bach JR
    Chest; 2017 May; 151(5):962-965. PubMed ID: 27989614
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of invasive ventilation is appropriate in children with genetically proven spinal muscular atrophy type 1: the motion against.
    Ryan MM
    Paediatr Respir Rev; 2008 Mar; 9(1):51-4; discussion 55-6. PubMed ID: 18280980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of mechanical ventilation is appropriate in children with genetically proven spinal muscular atrophy type 1: the motion for.
    Bach JR
    Paediatr Respir Rev; 2008 Mar; 9(1):45-50; quiz 50; discussion 55-6. PubMed ID: 18280979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respiratory support for the severely handicapped child with neuromuscular disease: ethics and practicality.
    Simonds AK
    Semin Respir Crit Care Med; 2007 Jun; 28(3):342-54. PubMed ID: 17562504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival in SMA type I: a prospective analysis of 34 consecutive cases.
    Cobben JM; Lemmink HH; Snoeck I; Barth PA; van der Lee JH; de Visser M
    Neuromuscul Disord; 2008 Jul; 18(7):541-4. PubMed ID: 18579378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spinal muscular atrophy--type I.
    Hardart MK; Truog RD
    Arch Dis Child; 2003 Oct; 88(10):848-50. PubMed ID: 14500298
    [No Abstract]   [Full Text] [Related]  

  • 14. Spinal muscular atrophy type 1: what are the ethics and practicality of respiratory support?
    Mitchell I
    Paediatr Respir Rev; 2006; 7 Suppl 1():S210-1. PubMed ID: 16798568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcome measures in spinal muscular atrophy.
    Montes J; Gordon AM; Pandya S; De Vivo DC; Kaufmann P
    J Child Neurol; 2009 Aug; 24(8):968-78. PubMed ID: 19509409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Respiratory support in spinal muscular atrophy type I: a survey of physician practices and attitudes.
    Hardart MK; Burns JP; Truog RD
    Pediatrics; 2002 Aug; 110(2 Pt 1):e24. PubMed ID: 12165623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing respiratory expectations with the new disease trajectory of nusinersen treated spinal muscular atrophy [SMA] type 1.
    Fitzgerald DA; Doumit M; Abel F
    Paediatr Respir Rev; 2018 Sep; 28():11-17. PubMed ID: 30414815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival of patients with spinal muscular atrophy type 1.
    Gregoretti C; Ottonello G; Chiarini Testa MB; Mastella C; Ravà L; Bignamini E; Veljkovic A; Cutrera R
    Pediatrics; 2013 May; 131(5):e1509-14. PubMed ID: 23610208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotype-phenotype studies in infantile spinal muscular atrophy (SMA) type I in Germany: implications for clinical trials and genetic counselling.
    Rudnik-Schöneborn S; Berg C; Zerres K; Betzler C; Grimm T; Eggermann T; Eggermann K; Wirth R; Wirth B; Heller R
    Clin Genet; 2009 Aug; 76(2):168-78. PubMed ID: 19780763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease impact on general well-being and therapeutic expectations of European Type II and Type III spinal muscular atrophy patients.
    Rouault F; Christie-Brown V; Broekgaarden R; Gusset N; Henderson D; Marczuk P; Schwersenz I; Bellis G; Cottet C
    Neuromuscul Disord; 2017 May; 27(5):428-438. PubMed ID: 28237437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.